-
-
-
-
-
-
-
Form S-1/A GeoVax Labs, Inc.
-
-
-
-
-
-
-
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
-
-
-
-
-
-
-
Form S-1 GeoVax Labs, Inc.
-
-
-
-
-
-
-
GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
-
-
-
-
-
-
-
GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review
-
-
-
-
-
-
-
GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA
-
-
-
-
-
-
-
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
-
66,650 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

